Should COVID-19 be considered cardiovascular disease risk equivalent?
- PMID: 36724830
- PMCID: PMC9884400
- DOI: 10.1016/j.ijcard.2023.01.076
Should COVID-19 be considered cardiovascular disease risk equivalent?
Conflict of interest statement
Declaration of Comp[eting Interest All authors declare that they have no potential conflicts of interest that might be relevant to the contents of this article.
Comment in
-
Reply to "Letter to the editor in response to the paper by Zuin et al. 2023".Int J Cardiol. 2023 Apr 1;376:26. doi: 10.1016/j.ijcard.2023.02.014. Epub 2023 Feb 12. Int J Cardiol. 2023. PMID: 36787868 Free PMC article. No abstract available.
Comment on
-
Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis.Int J Cardiol. 2023 Feb 1;372:138-143. doi: 10.1016/j.ijcard.2022.12.032. Epub 2022 Dec 16. Int J Cardiol. 2023. PMID: 36535564 Free PMC article.
References
-
- Schieffer B., Schieffer E., Hilfiker-Kleiner D., et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000;101(12):1372–1378. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
